Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
24/09/2024

Archive: 24/09/2024

Recognize bullying as a traumatic experience, urge authors of new report

A study lays bare the devastating impact of chronic bullying and has led to calls for more support for affected children, families and schools.

Sep 24, 2024

0

0

A microarray-based high-throughput in situ tagged immunoprecipitation sequencing technology for diffuse midline glioma

Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical regions of the central nervous system, such as the pons, thalamus, and spinal cord. Due to the high ...

Sep 24, 2024

0

0

Systemic immune-inflammation index tied to mortality in CKD

There is a J-shaped association between systemic immune-inflammation index (SII) levels and all-cause mortality in patients with chronic kidney disease (CKD), according to a study published online Sept. 10 in Immunity, Inflammation ...

Sep 24, 2024

0

0

Australian research reveals one in six children harmed by alcohol

New research undertaken by La Trobe University's Centre for Alcohol Policy Research shows one in six children (17.1%) have experienced harm from the alcohol use of adults around them, with two-thirds of harm being attributed ...

Sep 24, 2024

0

0

Skeletal muscle relaxants beneficial for only certain conditions

Long-term use of skeletal muscle relaxants (SMRs) for chronic pain is only effective for certain conditions, such as painful spasms, painful cramps, and neck pain, according to a review published online Sept. 19 in JAMA Network ...

Sep 24, 2024

0

0

Researchers identify genetic mutations for rare disorder causing cognitive decline

A rare cause of hereditary cognitive decline known as CSF1R-Related Disorder (CSF1R-RD) gets its name from mutations in the CSF1R gene, discovered by Mayo Clinic. Memory loss occurs as the condition advances, while early ...

Sep 24, 2024

0

177

Analytical tool quantifies cancer's ability to shape-shift

A powerful new analytical tool offers a closer look at how tumor cells "shape-shift" to become more aggressive and untreatable, as shown in a study by researchers at Weill Cornell Medicine and the New York Genome Center.

Sep 24, 2024

0

50

Maternal influenza infection in pregnancy tied to seizures in offspring

Maternal influenza infection during pregnancy is associated with an increased risk for seizures and febrile convulsions in offspring, according to a study published online Sept. 23 in JAMA Network Open.

Sep 24, 2024

0

0

Low-cost indoor air pollution monitoring helps protect children's health

University of Birmingham researchers have developed a low-cost means of measuring indoor air quality in schools—creating new opportunities to safeguard the health of young people.

Sep 24, 2024

0

1

Clinical trial: Cholesterol drug ineffective for treatment of multiple sclerosis

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow disability progression.

Sep 24, 2024

0

0

page 3 from 9

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2024 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us